Avalyn Pharma, Inc. (AVLN)
37.39
+1.95
(+5.50%)
USD |
NASDAQ |
Sep 04, 16:00
37.00
-0.39
(-1.04%)
After-Hours: 20:00
Avalyn Pharma Total Liabilities (Quarterly) : 27.10M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.10M |
| Date | Value |
|---|---|
| March 31, 2026 | 27.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.29M |
| CorMedix, Inc. | 443.22M |
| Eloxx Pharmaceuticals, Inc. | 16.97M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4631M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 425.45M |
| Shareholders Equity (Quarterly) | 398.35M |
| Debt to Equity Ratio | 0.043 |
| Current Ratio | 33.10 |
| Net Debt Paydown Yield | -0.20% |